Карта Jvector не работает, когда режим браузера и режим документа отличаются в IE8
В настоящее время я использую карту Jvector, и она хорошо работает. Я проверил, хорошо ли работает Internet Explorer. Я использую IE8. наконец, проверьте мою задачу, я установил режим браузера 8 и режим документа 7. затем запустите код, показывающий ошибку, как это?
Webpage error details
User Agent: Mozilla/4.0 (compatible; MSIE 7.0; Windows NT 6.1; SLCC2; .NET CLR 2.0.50727; .NET CLR 3.5.30729; .NET CLR 3.0.30729; Media Center PC 6.0; InfoPath.2; .NET4.0C; .NET4.0E)
Timestamp: Tue, 26 May 2015 13:47:52 UTC
Message: Expected identifier, string or number
Line: 290
Char: 13
Code: 0
URI: http://dotnetportfolio.com/project/Map/tests/basic1.html
помогите пожалуйста? как исправить эту ошибку? заранее спасибо
код:
<!DOCTYPE html>
<html>
<head>
<title>Country Footprint</title>
<link rel="stylesheet" media="all" href="../jquery-jvectormap.css"/>
<script src="assets/jquery-1.8.2.js"></script>
<script src="../jquery-jvectormap.js"></script>
<script src="../lib/jquery-mousewheel.js"></script>
<script src="../src/jvectormap.js"></script>
<script src="../src/abstract-element.js"></script>
<script src="../src/abstract-canvas-element.js"></script>
<script src="../src/abstract-shape-element.js"></script>
<script src="../src/svg-element.js"></script>
<script src="../src/svg-group-element.js"></script>
<script src="../src/svg-canvas-element.js"></script>
<script src="../src/svg-shape-element.js"></script>
<script src="../src/svg-path-element.js"></script>
<script src="../src/svg-circle-element.js"></script>
<script src="../src/svg-image-element.js"></script>
<script src="../src/svg-text-element.js"></script>
<script src="../src/vml-element.js"></script>
<script src="../src/vml-group-element.js"></script>
<script src="../src/vml-canvas-element.js"></script>
<script src="../src/vml-shape-element.js"></script>
<script src="../src/vml-path-element.js"></script>
<script src="../src/vml-circle-element.js"></script>
<script src="../src/vml-image-element.js"></script>
<script src="../src/map-object.js"></script>
<script src="../src/region.js"></script>
<script src="../src/marker.js"></script>
<script src="../src/vector-canvas.js"></script>
<script src="../src/simple-scale.js"></script>
<script src="../src/ordinal-scale.js"></script>
<script src="../src/numeric-scale.js"></script>
<script src="../src/color-scale.js"></script>
<script src="../src/legend.js"></script>
<script src="../src/data-series.js"></script>
<script src="../src/proj.js"></script>
<script src="../src/map.js"></script>
<script src="assets/jquery-jvectormap-world-mill-en.js"></script>
<script>
jQuery.noConflict();
jQuery(function(){
var $ = jQuery;
$('#focus-single').click(function(){
$('#map1').vectorMap('set', 'focus', {region: 'AU', animate: true});
});
$('#focus-multiple').click(function(){
$('#map1').vectorMap('set', 'focus', {regions: ['AU', 'JP'], animate: true});
});
$('#focus-coords').click(function(){
$('#map1').vectorMap('set', 'focus', {scale: 7, lat: 35, lng: 33, animate: true});
});
$('#focus-init').click(function(){
$('#map1').vectorMap('set', 'focus', {scale: 1, x: 0.5, y: 0.5, animate: true});
});
$('#map1').vectorMap({
map: 'world_mill_en',
panOnDrag: true,
focusOn: {
x: 0.5,
y: 0.5,
scale: 1,
animate: true
},
series: {
regions: [{
scale: ['#688FA0'],
normalizeFunction: 'polynomial',
values: {
//"DZ": 158.97,
// "AZ":1.1,
"AG": 1.1,
// "AE":7.54,
// "AO":5.6,
"AR": 351.02,
//"AM":3.96,
"AU": 1219.72,
"AT": 366.26,
//"AF":3.96,
// "AL":3.96,
//"BS": 7.54,
"BH": 21.73,
// "BI":4.45,
"BB": 3.96,
//"BY": 52.89,
"BE": 461.33,
// "BT":7.54,
// "BD":7.54,
// "BW":9.3,
// "BA": 16.2,
// "BF":4.6,
// "BR": 2023.53,
}
}]
},
onRegionTipShow: function(e, label, code){
var code=label.html();
switch(code){
case 'Argentina' :
label.html("<div style='height:129px;width:296px;Length:98px'><b>Country</b>:  Argentina<br/><b>Category</b>:  Approved<br/><b>PDP GCO Region</b>:  South America<br/><b>Comments</b>:  Have had delays with regulatory submissions/approvals. As long as advanced planning is taken into consideration this country should be okay.</br><b>CCL</b>:  Mariana Bodmer</div>");
break;
case 'Australia' :
label.html("<div style='height:78px;Length:88px'><b>Country</b>:  Australia<br/><b>Category</b>:  Approved<br/><b>PDP GCO Region</b>:  ROW</br><b>Comments</b>:  None <br/><b>CCL</b>:  Michelle Barrington</div>");
break;
case 'Belgium' :
label.html("<div style='height:78px;Length:78px'><b>Country</b>:  Belgium<br/><b>Category</b>:  Approved<br/><b>PDP GCO Region</b>:  Europe</br><b>Comments</b>:  None<br/><b>CCL</b>:  Marleen Van Kerckhoven</div>");
break;
case 'Brazil' :
label.html("<div style='height:148px;width:490px;Length:198px'><b>Country</b>:  Brazil<br/><b>Category</b>:  Requires Approval<br/><b>PDP GCO Region</b>:  South America<br/><b>Comments</b>:  There are concerns with country stipulations regarding provisions and rights to study medication, following protocol treatment, regardless of commercialization. Also issues from the regulatory governance.A Advanced planning in place surrounding the CTA and country setup in Brazil, as it can take close to 12 months.</div>");
break;
default :
label.html(
"<div style='height:15px;font-size: 11px;font-family: Verdana, sans-serif;padding: 1px;white-space: pre-line'>" + code + "</div>");
break;
}
},
});
})
</script>